Psychiatry — API & Bulk Drug Suppliers in India

selective norepinephrine reuptake inhibitor — capsule formulations for attention deficit hyperactivity disorder.

SNRI — capsule formulations for depression, anxiety, neuropathic pain and fibromyalgia.

SSRI — tablet and solution formulations for depression and anxiety disorders.

SSRI — capsule formulations for depression, OCD and bulimia.

SSRI with sigma-receptor activity — tablet formulations for OCD and anxiety disorders.

nicotine replacement active — gum and lozenge formulations for smoking cessation.

SSRI — tablet formulations for depression, anxiety and OCD.

atypical antipsychotic — tablet formulations for schizophrenia, bipolar disorder and as adjunct in depression.

SNRI — tablet and capsule formulations for depression and anxiety disorders.

short-acting benzodiazepine anxiolytic — tablet formulations for anxiety and panic disorder under controlled-drug rules.

tricyclic antidepressant — tablet formulations for depression, neuropathic pain and migraine prophylaxis.

dopamine partial-agonist antipsychotic — tablet formulations for schizophrenia, bipolar disorder and adjunct use in depression.

long-acting benzodiazepine — tablet formulations for seizures and panic disorder under controlled-drug rules.

noradrenergic and specific serotonergic antidepressant — tablet formulations for depression with sleep disturbance.

atypical antipsychotic — tablet formulations for schizophrenia and bipolar disorder.

atypical antipsychotic — tablet and solution formulations for schizophrenia and mania.

SSRI antidepressant — tablet formulations for depression, anxiety and OCD.

Z-drug hypnotic — tablet formulations for short-term insomnia under controlled-drug rules.

norepinephrine-dopamine reuptake inhibitor — tablet formulations for depression and smoking cessation.

5-HT1A partial agonist anxiolytic — tablet formulations for generalised anxiety without sedation.

1,5-benzodiazepine — tablet formulations for anxiety and adjunct therapy in seizures.

atypical antipsychotic — tablet formulations for treatment-resistant schizophrenia under monitoring protocols.

SNRI antidepressant — extended-release tablet formulations for major depression.

long-acting benzodiazepine — tablet and injection formulations for anxiety, muscle spasm and status epilepticus.

typical antipsychotic — tablet and injection formulations for psychosis and acute agitation.

intermediate-acting benzodiazepine — tablet and injection formulations for anxiety and acute agitation.

central stimulant — tablet formulations, including extended-release, for ADHD under controlled-drug rules.

ultra-short-acting benzodiazepine — injection and buccal formulations for sedation and acute seizures.

wakefulness-promoting agent — tablet formulations for narcolepsy and shift-work sleep disorder.

serotonin antagonist-reuptake inhibitor — tablet formulations for depression with insomnia.